BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35596897)

  • 21. BCOR Overexpression Is a Highly Sensitive Marker in Round Cell Sarcomas With BCOR Genetic Abnormalities.
    Kao YC; Sung YS; Zhang L; Jungbluth AA; Huang SC; Argani P; Agaram NP; Zin A; Alaggio R; Antonescu CR
    Am J Surg Pathol; 2016 Dec; 40(12):1670-1678. PubMed ID: 27428733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue.
    Yoshida Y; Nobusawa S; Nakata S; Nakada M; Arakawa Y; Mineharu Y; Sugita Y; Yoshioka T; Araki A; Sato Y; Takeshima H; Okada M; Nishi A; Yamazaki T; Kohashi K; Oda Y; Hirato J; Yokoo H
    Brain Pathol; 2018 Sep; 28(5):710-720. PubMed ID: 29226988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel BCOR-MAML3 and ZC3H7B-BCOR Gene Fusions in Undifferentiated Small Blue Round Cell Sarcomas.
    Specht K; Zhang L; Sung YS; Nucci M; Dry S; Vaiyapuri S; Richter GH; Fletcher CD; Antonescu CR
    Am J Surg Pathol; 2016 Apr; 40(4):433-42. PubMed ID: 26752546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure and Role of BCOR PUFD in Noncanonical PRC1 Assembly and Disease.
    Wong SJ; Senkovich O; Artigas JA; Gearhart MD; Ilangovan U; Graham DW; Abel KN; Yu T; Hinck AP; Bardwell VJ; Kim CA
    Biochemistry; 2020 Jul; 59(29):2718-2728. PubMed ID: 32628469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis.
    Terada K; Yamaguchi H; Ueki T; Usuki K; Kobayashi Y; Tajika K; Gomi S; Kurosawa S; Saito R; Furuta Y; Miyadera K; Tokura T; Marumo A; Omori I; Sakaguchi M; Fujiwara Y; Yui S; Ryotokuji T; Arai K; Kitano T; Wakita S; Fukuda T; Inokuchi K
    Genes Chromosomes Cancer; 2018 Aug; 57(8):401-408. PubMed ID: 29663558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BCOR upregulation in a poorly differentiated synovial sarcoma with SS18L1-SSX1 fusion-A pathologic and molecular pitfall.
    Kao YC; Sung YS; Zhang L; Kenan S; Singer S; Tap WD; Swanson D; Dickson BC; Antonescu CR
    Genes Chromosomes Cancer; 2017 Apr; 56(4):296-302. PubMed ID: 27914109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCOR-CCNB3 Fusion Positive Sarcomas: A Clinicopathologic and Molecular Analysis of 36 Cases With Comparison to Morphologic Spectrum and Clinical Behavior of Other Round Cell Sarcomas.
    Kao YC; Owosho AA; Sung YS; Zhang L; Fujisawa Y; Lee JC; Wexler L; Argani P; Swanson D; Dickson BC; Fletcher CDM; Antonescu CR
    Am J Surg Pathol; 2018 May; 42(5):604-615. PubMed ID: 29300189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss.
    Lin DI; Hemmerich A; Edgerly C; Duncan D; Severson EA; Huang RSP; Ramkissoon SH; Connor YD; Shea M; Hecht JL; Ali SM; Vergilio JA; Ross JS; Elvin JA
    Gynecol Oncol; 2020 May; 157(2):357-366. PubMed ID: 32156473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superficial malignant ossifying fibromyxoid tumors harboring the rare and recently described ZC3H7B-BCOR and PHF1-TFE3 fusions.
    Linos K; Kerr DA; Baker M; Wong S; Henderson E; Sumegi J; Bridge JA
    J Cutan Pathol; 2020 Oct; 47(10):934-945. PubMed ID: 32352579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.
    Damm F; Chesnais V; Nagata Y; Yoshida K; Scourzic L; Okuno Y; Itzykson R; Sanada M; Shiraishi Y; Gelsi-Boyer V; Renneville A; Miyano S; Mori H; Shih LY; Park S; Dreyfus F; Guerci-Bresler A; Solary E; Rose C; Cheze S; Prébet T; Vey N; Legentil M; Duffourd Y; de Botton S; Preudhomme C; Birnbaum D; Bernard OA; Ogawa S; Fontenay M; Kosmider O
    Blood; 2013 Oct; 122(18):3169-77. PubMed ID: 24047651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central nervous system high-grade neuroepithelial tumor with BCOR alteration (CNS HGNET-BCOR)-case-based reviews.
    De Lima L; Sürme MB; Gessi M; Mastronuzzi A; Miele E; Tamburrini G; Massimi L
    Childs Nerv Syst; 2020 Aug; 36(8):1589-1599. PubMed ID: 32542405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel ZC3H7B-BCOR, MEAF6-PHF1, and EPC1-PHF1 fusions in ossifying fibromyxoid tumors--molecular characterization shows genetic overlap with endometrial stromal sarcoma.
    Antonescu CR; Sung YS; Chen CL; Zhang L; Chen HW; Singer S; Agaram NP; Sboner A; Fletcher CD
    Genes Chromosomes Cancer; 2014 Feb; 53(2):183-93. PubMed ID: 24285434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent mutations in other epigenetic modulators portend better prognosis in BCOR-mutated myelodysplastic syndrome.
    Badaat I; Mirza S; Padron E; Sallman D; Komrokji R; Song J; Hussaini MO
    J Clin Pathol; 2020 Apr; 73(4):209-212. PubMed ID: 31771970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. When molecular outsmarts morphology: Malignant ossifying fibromyxoid tumors masquerading as osteosarcomas, including a novel CREBZF::PHF1 fusion.
    Sharma AE; Dermawan JK; Sherrod AE; Chopra S; Maki RG; Antonescu CR
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23206. PubMed ID: 37819540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent BCOR Internal Tandem Duplication and YWHAE-NUTM2B Fusions in Soft Tissue Undifferentiated Round Cell Sarcoma of Infancy: Overlapping Genetic Features With Clear Cell Sarcoma of Kidney.
    Kao YC; Sung YS; Zhang L; Huang SC; Argani P; Chung CT; Graf NS; Wright DC; Kellie SJ; Agaram NP; Ludwig K; Zin A; Alaggio R; Antonescu CR
    Am J Surg Pathol; 2016 Aug; 40(8):1009-20. PubMed ID: 26945340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemia.
    Tiacci E; Grossmann V; Martelli MP; Kohlmann A; Haferlach T; Falini B
    Haematologica; 2012 Jan; 97(1):3-5. PubMed ID: 22210327
    [No Abstract]   [Full Text] [Related]  

  • 37. BCOR-CCNB3 sarcoma with concurrent RNF213-SLC26A11 gene fusion: a rare sarcoma with altered histopathological features after chemotherapy.
    Huang W; Wang W; Huang LL; Li H; Zhou WC; Wu HB
    World J Surg Oncol; 2022 May; 20(1):156. PubMed ID: 35568949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of "CNS tumors with BCOR internal tandem duplication".
    Tauziède-Espariat A; Pierron G; Siegfried A; Guillemot D; Uro-Coste E; Nicaise Y; Castel D; Catalaa I; Larrieu-Ciron D; Chaynes P; de Barros A; Nicolau J; Gareton A; Lechapt E; Chrétien F; Bourdeaut F; Doz F; Bouchoucha Y; Grill J; Beccaria K; Boddaert N; Saffroy R; Pagès M; Varlet P
    Acta Neuropathol Commun; 2020 Nov; 8(1):178. PubMed ID: 33138864
    [No Abstract]   [Full Text] [Related]  

  • 39. Nuclear import of transcriptional corepressor BCOR occurs through interaction with karyopherin α expressed in human periodontal ligament.
    Myat AB; Ogawa T; Kadota-Watanabe C; Moriyama K
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):67-73. PubMed ID: 30396568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary Renal Sarcomas With BCOR-CCNB3 Gene Fusion: A Report of 2 Cases Showing Histologic Overlap With Clear Cell Sarcoma of Kidney, Suggesting Further Link Between BCOR-related Sarcomas of the Kidney and Soft Tissues.
    Argani P; Kao YC; Zhang L; Bacchi C; Matoso A; Alaggio R; Epstein JI; Antonescu CR
    Am J Surg Pathol; 2017 Dec; 41(12):1702-1712. PubMed ID: 28817404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.